Cilostazol After Lower Extremity Arterial Revascularization Trial (CLEAR)
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Cilostazol (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms CLEAR
- 20 Oct 2017 Status changed from active, no longer recruiting to completed.
- 01 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Aug 2017.
- 01 Jun 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Aug 2017.